CLINICAL ROLE -
A discussion on advancements and updates in the treatment of CLL, including the latest research presented at the 2021 American Society of Clinical Oncology Virtual Meeting.
EP. 1: CLL: Treatment Paradigm Shifts and Impact on Outcomes
Kirollos S. Hanna, PharmD, BCPS, BCOP, provides an overview of the shifts in treatments, trends, and outcomes seen over the past decade in CLL.
EP. 2: NCCN Guidelines: Rapid Change in CLL Treatment Concepts
Taylor M. Weis, PharmD, BCOP, discusses NCCN guidelines for first-line therapy as well as the rationale behind the rapid change in treatment concepts for CLL.
EP. 3: Therapy Initiation and Treatment Goals in CLL
Experts discuss triggers for initiating therapy in a patient with CLL, in addition to the goals of therapy.
EP. 4: Long-Term Data on the Use of BTK Inhibitors in CLL
A review of long-term efficacy and safety data on the use of BTK inhibitor monotherapy in the frontline setting, plus insights from clinical practice.
EP. 5: Toxicity Management for BTK Inhibitors: Pharmacist’s Role
Taylor M. Weis, PharmD, BCOP, discusses the role of pharmacists in toxicity prevention and management with BTK inhibitor therapy in CLL.
EP. 6: Head-to-Head BTK Inhibitor Data and Cardiovascular Toxicity
Experts discuss the results of a head-to-head trial of ibrutinib versus acalabrutinib in CLL and the cardiovascular toxicity associated with BTK inhibitors.
EP. 7: BTK Inhibitor in Combination With Anti-CD20 mAb for CLL
Taylor M. Weis, PharmD, BCOP, discusses data on a BTK inhibitor in combination with anti-CD20 monoclonal antibodies in the treatment of CLL.
EP. 8: BCL2 Inhibitor in Combination With Anti-CD20 mAb for CLL
Kirollos S. Hanna, PharmD, BCPS, BCOP, discusses data on a BCL2 inhibitor in combination with anti-CD20 monoclonal antibodies in the treatment of CLL.
EP. 9: BTKi-Based Vs BCL2i-Based Regimens in CLL
Experts discuss factors and approaches to consider if choosing between a BTKi-based and BCL2i-based regimen for frontline therapy in CLL.
EP. 10: Emerging Therapies in CLL
Emerging combination therapies and novel agents being studied as initial therapy for CLL are discussed.
EP. 11: Advice for Optimizing Treatment Success in CLL
Experts share final thoughts and advice for clinicians in the community to help optimize treatment success in CLL.
2 Clarke Drive Cranbury, NJ 08512